Nanobiotix

Julie Marill

Laurent Levy

Agnes Pottier

Matthieu Germain

Agnès Pottier

Annabelle Rouet

Corinne Devaux

The present invention relates to the field of human health and more particularly concerns nanoparticles for use as a therapeutic vaccine in the context of radiotherapy in a subject suffering of a cancer, in particular of a metastatic cancer or of a liquid cancer.

Nanoparticles for use as a therapeutic vaccine

The present application relates to novel excitable particles which can be used in the health sector. It more particularly relates to particles which can generate electrons and/or high energy photon when excited by ionizing radiations such as X-Rays, &#x3b3;-Rays, radioactive isotope and/or electron beams, and to the uses thereof in health, in particular in human health. The inventive particles are made of an inorganic material comprising oxygen, in particular an oxide, said material having an adequate density, and can be activated in vitro, ex vivo, or in vivo, by controllable external excitation, in order to disturb, alter or destroy target cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or medical device compositions containing same.

Inorganic nanoparticles of high density to destroy cells in-vivo

Growing community of inventors

Le Perreux sur Marne, France

Julie Marill